605507 logo

Guobang Pharma Ltd. Stock Price

SHSE:605507 Community·CN¥14.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

605507 Share Price Performance

CN¥0
-21.35 (-100.00%)
CN¥0
-21.35 (-100.00%)
Price CN¥0

605507 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with acceptable track record.

2 Risks
1 Reward

Guobang Pharma Ltd. Key Details

CN¥6.0b

Revenue

CN¥4.4b

Cost of Revenue

CN¥1.6b

Gross Profit

CN¥744.0m

Other Expenses

CN¥820.8m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Apr 16, 2026
1.48
26.03%
13.65%
11.6%
View Full Analysis

About 605507

Founded
1996
Employees
4003
CEO
Shixue Liao
WebsiteView website
www.gbgcn.com

Guobang Pharma Ltd. engages in the research, development, production, and sale of products in the pharmaceutical and veterinary industries. The company offers pharmaceutical products, including quinolones, macrolides, cephalosporins, characteristic APIs, preparations and accessories, and key pharmaceutical intermediates; and mobile protection APIs, kinetophoretic preparations, and feed additives. It sells its products approximately in 115 countries and regions worldwide. Guobang Pharma Ltd. was founded in 1996 and is based in Xinchang, China.

Recent 605507 News & Updates

Recent updates

No updates